Atsuko Fujihara

Atsuko Fujihara

Auto-generated profile, based on publicly available information

Atsuko Fujihara

Department of Urology, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2022 in International Journal of Urology
Verified
Journal Article
Closed access
AFAtsuko Fujihara
Atsuko Fujihara
OUOsamu Ukimura
Osamu Ukimura

28 March 2011 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
AFAtsuko Fujihara
Atsuko Fujihara
OUOsamu Ukimura
Osamu Ukimura
TITsuyoshi Iwata
Tsuyoshi Iwata
TMTsuneharu Miki
Tsuneharu Miki
Sensory dysfunction could be involved in various pathogeneses in the lower urinary tract including neurogenic bladder, overactive bladder, painful bladder syndrome and neuropathy as a result of endocrine disorders. The ability to diagnose sensory function more objectively is of increasing interest to clinicians. Afferent innervations of the lower urinary tract involve myelinated (A‐delta) and unmyelinated (C) fibers. The Neurometer (Neurotron, Baltimore, MD, USA) is the only reported commercially available device to evaluate afferent function by selectively depolarizing different subpopulations of afferent nerves, with 250 Hz activating A‐delta fibers and 5 Hz activating C‐fibers, to determine their current perception threshold (CPT) as a quantitative measure. Recently, increased evidence has suggested that measurement of CPT values of A‐delta and C‐fibers in the lower urinary tracts is feasible and shows significant correlation with clinical symptoms and conventional urodynamic variables, as well as the efficacy of various treatments. However, there are still controversial issues in the wider use of this technology in diagnosis and assessment of the therapeutic effectiveness of sensory dysfunction in the lower urinary tracts. In order to resolve the remaining challenges in the CPT test of the lower urinary tract, recent efforts include development of a new balloon‐type electro‐catheter with dual electrodes as an alternative sensory test for the bladder or urethra, which allows simultaneous performance of conventional urodynamic tests and urine collection, and future standardized techniques available for comparison with validated control values.

11 October 2020 in BJU International
Verified
Journal Article
Closed access
PDF file
AFAtsuko Fujihara
Atsuko Fujihara
TITsuyoshi Iwata
Tsuyoshi Iwata
ASAliasger Shakir
Aliasger Shakir
ATAlessandro Tafuri
Alessandro Tafuri
GCGiovanni E. Cacciamani
Giovanni E. Cacciamani
AAAndre Luis Abreu
Andre Luis Abreu

29 July 2020 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
YYYasuhiro Yamada
Yasuhiro Yamada
OUOsamu Ukimura
Osamu Ukimura
MKMasatomo Kaneko
Masatomo Kaneko
TMToru Matsugasumi
Toru Matsugasumi
AFAtsuko Fujihara
Atsuko Fujihara
Jean de la RosetteJean de la Rosette
Jean de la Rosette

26 May 2022 in BJU International
Verified
Journal Article
Closed access
HBHidehisa Boku
Hidehisa Boku
MKMasatomo Kaneko
Masatomo Kaneko
YYYasuhiro Yamada
Yasuhiro Yamada
YMYukiko Morinaga
Yukiko Morinaga
EKEiichi Konishi
Eiichi Konishi
OUOsamu Ukimura
Osamu Ukimura

1 June 2024 in International braz j urol
Verified
Journal Article
Open access
PDF file
MKMasatomo Kaneko
Masatomo Kaneko
AFAtsuko Fujihara
Atsuko Fujihara
TITsuyoshi Iwata
Tsuyoshi Iwata
LRLorenzo Storino Ramacciotti
Lorenzo Storino Ramacciotti
SPSuzanne L. Palmer
Suzanne L. Palmer
AAAndre Luis Abreu
Andre Luis Abreu
Purpose: To create a nomogram to predict the absence of clinically significant prostate cancer (CSPCa) in males with non-suspicion multiparametric magnetic resonance imaging (mpMRI) undergoing prostate biopsy (PBx).